ATE231727T1 - Zusammensetzung für verbesserung der pankreasfunktion - Google Patents

Zusammensetzung für verbesserung der pankreasfunktion

Info

Publication number
ATE231727T1
ATE231727T1 AT96937535T AT96937535T ATE231727T1 AT E231727 T1 ATE231727 T1 AT E231727T1 AT 96937535 T AT96937535 T AT 96937535T AT 96937535 T AT96937535 T AT 96937535T AT E231727 T1 ATE231727 T1 AT E231727T1
Authority
AT
Austria
Prior art keywords
composition
cells
improvement
pancreas function
pancreatic
Prior art date
Application number
AT96937535T
Other languages
English (en)
Inventor
Itaru Kojima
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE231727T1 publication Critical patent/ATE231727T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT96937535T 1995-11-09 1996-11-08 Zusammensetzung für verbesserung der pankreasfunktion ATE231727T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29123895 1995-11-09
PCT/JP1996/003277 WO1997017086A2 (en) 1995-11-09 1996-11-08 Composition for improving pancreatic function

Publications (1)

Publication Number Publication Date
ATE231727T1 true ATE231727T1 (de) 2003-02-15

Family

ID=17766273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96937535T ATE231727T1 (de) 1995-11-09 1996-11-08 Zusammensetzung für verbesserung der pankreasfunktion

Country Status (8)

Country Link
US (1) US6232288B1 (de)
EP (1) EP0862451B1 (de)
CN (1) CN1202112A (de)
AT (1) ATE231727T1 (de)
AU (1) AU7506396A (de)
CA (1) CA2233009C (de)
DE (1) DE69626034T2 (de)
WO (1) WO1997017086A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6366999A (en) * 1998-10-30 2000-05-22 Takeda Chemical Industries Ltd. Betacellulin protein-containing preparations
DK1148129T3 (da) 1998-12-09 2007-10-15 Takeda Pharmaceutical Modifikation af betacellulin
AU2005201435A1 (en) * 1999-04-06 2005-04-28 Genentech, Inc. Use of ErbB receptor ligands in treating diabetes
JP4794049B2 (ja) * 1999-04-06 2011-10-12 ジェネンテック， インコーポレイテッド 糖尿病治療へのＥｒｂＢレセプターリガンドの使用
US20020099008A1 (en) 1999-04-26 2002-07-25 Daniel R. Twardzik Method for stimulating hematopoiesis using tgf-alpha
ATE364315T1 (de) 1999-04-26 2007-07-15 Applied Protein Sciences Llc Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
US20020193301A1 (en) 1999-08-19 2002-12-19 Stem Cell Pharmaceuticals, Inc. TGF-alpha polypeptides, functional fragments and methods of use therefor
US6815418B2 (en) * 1999-08-19 2004-11-09 Kaleidos Pharma, Inc. TGF-α polypeptides, functional fragments and methods of use therefor
US6677307B2 (en) 1999-08-19 2004-01-13 Kaleidos Pharma, Inc. TGF-α polypeptides, functional fragments and methods of use therefor
WO2002024148A2 (en) * 2000-09-22 2002-03-28 Stem Cell Pharmaceuticals Inc. Method or treatment of tumors using transforming growth factor-alpha
CA2442177A1 (en) * 2001-03-29 2002-10-10 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
CN100516204C (zh) * 2001-04-24 2009-07-22 味之素株式会社 干细胞及其分离方法
US20040132679A1 (en) * 2002-09-03 2004-07-08 Baylor College Of Medicine Induction of pancreatic islet formation
EP1629851A1 (de) * 2003-04-15 2006-03-01 Chugai Seiyaku Kabushiki Kaisha Mittel zur behandlung von diabetes
TWI323125B (en) 2004-04-16 2010-04-01 Hon Hai Prec Ind Co Ltd An method for auto-adjusting the focus of the digital camera
JP2008529498A (ja) * 2005-02-03 2008-08-07 バイオテック インスティテュート フォー インターナショナル イノベーション，インク． 糖尿病治療用組成物類および方法
CA2584968C (en) 2005-05-17 2010-08-17 Morinaga Milk Industry Co., Ltd. Drug and food or drink for improving pancreatic functions
KR101030247B1 (ko) 2005-05-17 2011-04-22 모리나가 뉴교 가부시키가이샤 췌장 기능 개선을 위한 음식품
EP1882472B1 (de) 2005-05-17 2018-08-22 Morinaga Milk Industry Co., Ltd. Arzneimittel, lebensmittel oder getränk zur verbesserung der pankreatischen funktionen
CA2609728A1 (en) * 2005-05-27 2006-11-30 Five Prime Therapeutics, Inc. Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
CN101573445A (zh) * 2006-09-22 2009-11-04 贝勒研究院 由胰腺腺泡细胞向胰岛素生成细胞的体内转化

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2099304T3 (es) 1992-02-10 1997-05-16 Takeda Chemical Industries Ltd Mitogeno de la musculatura lisa y adn que lo codifica.

Also Published As

Publication number Publication date
DE69626034T2 (de) 2003-08-14
CN1202112A (zh) 1998-12-16
CA2233009A1 (en) 1997-05-15
EP0862451A2 (de) 1998-09-09
DE69626034D1 (de) 2003-03-06
AU7506396A (en) 1997-05-29
WO1997017086A2 (en) 1997-05-15
US6232288B1 (en) 2001-05-15
WO1997017086A3 (en) 1997-06-19
EP0862451B1 (de) 2003-01-29
CA2233009C (en) 2005-05-10

Similar Documents

Publication Publication Date Title
DE69626034D1 (de) Zusammensetzung für verbesserung der pankreasfunktion
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
NO971566L (no) Fremgangsmåte for behandling av diabetes mellitus ved anvendelse av KGF
ATE186305T1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
AU1402788A (en) Vascular anticoagulant proteins
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
PT809437E (pt) Tiois para promover crescimento de celulas progenitoras hematopoieticas
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
PT779896E (pt) Processo novo para a producao de proteina com actividade biologica
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
DE69014046D1 (de) Verzweigungsenzym und dessen Verwendung.
DK461787D0 (da) Fremgangsmaade til selektivt at foroege maengdeforholdet mellem enkelte hovedkomponenter af antibiotikum a/16686-kompleks
FI942442A0 (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
DK461887D0 (da) Fremgangsmaade til selektivt at foroege andelen af enkelte hovedkomponenter af antibiotikum a 40926-kompleks
DE69535263D1 (de) Angiotensin ii zur verbesserung der befruchtung
EP0354323A3 (de) Antidiabetische Phosphate
UA26870C2 (uk) Спосіб підвищеhhя продукуваhhя протеїhу с, спосіб підвищеhhя рівhя його модифікації
ES2166800T3 (es) Procedimiento para la preparacion de o,s-acetales de 2,2-difluoroceteno sililo y o,s-esteres del acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolan-4-propanoico.
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ATE265526T1 (de) Genetisch veränderte fibroblasten und ihre verwendung
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
DE69929683D1 (de) Antisense modulierung von lfa-3

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties